BioCardia, Inc. (BCDA)

NASDAQ

$0.93

$+0.01

(+1.47%)

Regular Market

BioCardia, Inc. (BCDA) Live Price Chart

Last updated: ⁦2026-10-28 19:18:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

BioCardia, Inc. (BCDA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.93, with a market capitalization of $13.65M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.75 to $1.80. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13.65M
Open	$0.89
Day's High	$129.00
Day's Low	$0.75
Previous Close	$0.92
Volume	13.62K
Average Volume	248.07K
P/E Ratio	--
52-Week High	$1.80
52-Week Low	$0.75
Dividend Yield	--
Earnings Date	--

BioCardia, Inc. (BCDA) Stock Price Today

BioCardia, Inc. (BCDA) is currently trading at $0.93 as of 2026-10-28 19:16:00, up 1.14% ($0.01) from the previous close of $0.92

During today's regular trading session, BCDA has traded between $0.75 and $129.00, with a trading volume of 13.62K shares. The current price is near the lower end of today's range.

BioCardia, Inc. (BCDA) 7-Day Stock Price Change

Over the past seven days, BioCardia, Inc. (BCDA) moved from $0.90 to $0.93, representing a gain of 3.84% ($0.03).

The stock traded between $0.86 and $1.07 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 149.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BCDA 52-Week Price Position

Position in Range: 17.3%

52W Low$0.75

52W High$1.80

BCDA is currently trading at $0.93, placing it 17.3% of the way from its 52-week low of $0.75 to its 52-week high of $1.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BioCardia, Inc. (BCDA)?

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

BioCardia, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	21
Exchange	NASDAQ
Company Website	https://www.biocardia.com

How to Buy BioCardia, Inc. (BCDA) Stock on MEXC

Eligible investors can buy real shares of BioCardia, Inc. (BCDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BCDA and Place Your Order

Open the RealStocks trading page and search for BCDA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BioCardia, Inc. (BCDA) stock price today?

BioCardia, Inc. (BCDA) is currently trading at $ 0.93, up 1.14% ($0.01) from the previous close of $ 0.92. Intraday prices update in real time during regular trading hours.

2.Is BCDA stock going up or down today?

As of 2026-10-28 19:16:00, BCDA is trading at $ 0.93, up 1.14% ($0.01) from its previous close of $ 0.92. The stock has traded between $ 0.75 and $ 129.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is BCDA pre-market price?

As of 2026-10-28 19:16:00, BCDA is trading at $ 0.96 in pre-market trading, up 4.18% ($0.04) from the previous close of $ 0.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BCDA after-hours price?

As of 2026-10-28 19:16:00, BCDA is trading at $ 0.89 in after-hours trading, down 3.20% ($0.03) from the regular-session close of $ 0.92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BCDA stock trading now?

BCDA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BCDA sit relative to its 52-week high and low?

Over the past 52 weeks, BCDA has traded between a low of $ 0.75 and a high of $ 1.80. At $ 0.93, the stock is positioned 17.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BioCardia, Inc. in?

BioCardia, Inc. (BCDA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BioCardia, Inc.'s market capitalization and where is it listed?

BioCardia, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 13.65M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BCDA valued in terms of P/E ratio and EPS?

BCDA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.48. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BioCardia, Inc. pay a dividend?

BioCardia, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.